Free Trial

Sei Investments Co. Has $26.23 Million Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Ryan Specialty logo with Finance background
Remove Ads

Sei Investments Co. trimmed its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 19.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 408,777 shares of the company's stock after selling 95,973 shares during the quarter. Sei Investments Co. owned approximately 0.16% of Ryan Specialty worth $26,227,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Intech Investment Management LLC increased its position in shares of Ryan Specialty by 61.8% in the third quarter. Intech Investment Management LLC now owns 16,544 shares of the company's stock worth $1,098,000 after acquiring an additional 6,316 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Ryan Specialty by 43.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 938,187 shares of the company's stock worth $62,286,000 after purchasing an additional 286,380 shares during the period. Great Valley Advisor Group Inc. purchased a new position in Ryan Specialty during the 3rd quarter worth approximately $346,000. Loomis Sayles & Co. L P raised its stake in Ryan Specialty by 26.3% during the 3rd quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company's stock valued at $91,000 after purchasing an additional 286 shares during the period. Finally, FMR LLC lifted its holdings in shares of Ryan Specialty by 72.3% in the third quarter. FMR LLC now owns 12,875 shares of the company's stock valued at $855,000 after purchasing an additional 5,402 shares in the last quarter. 84.82% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Ryan Specialty Stock Performance

Shares of RYAN stock traded up $0.15 during trading on Friday, reaching $72.98. The company had a trading volume of 860,892 shares, compared to its average volume of 930,027. The firm's 50 day simple moving average is $68.74 and its two-hundred day simple moving average is $68.32. Ryan Specialty Holdings, Inc. has a one year low of $48.48 and a one year high of $75.97. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The company has a market capitalization of $19.11 billion, a PE ratio of 105.77, a PEG ratio of 1.19 and a beta of 0.71.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). The firm had revenue of $663.53 million during the quarter, compared to the consensus estimate of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. Sell-side analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th were paid a $0.12 dividend. The ex-dividend date was Tuesday, March 4th. This is a positive change from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.66%. Ryan Specialty's payout ratio is presently 69.57%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. UBS Group increased their price objective on Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Wells Fargo & Company increased their price target on shares of Ryan Specialty from $64.00 to $69.00 and gave the stock an "equal weight" rating in a research report on Friday, February 21st. Keefe, Bruyette & Woods lowered their price objective on shares of Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating on the stock in a research report on Friday, February 21st. Morgan Stanley began coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They issued an "overweight" rating and a $90.00 target price for the company. Finally, Royal Bank of Canada lowered their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a report on Friday, February 21st. One research analyst has rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, Ryan Specialty currently has an average rating of "Hold" and an average target price of $75.27.

Get Our Latest Stock Report on RYAN

Insider Activity at Ryan Specialty

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the company's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Nicholas Dominic Cortezi sold 29,466 shares of the stock in a transaction dated Monday, January 13th. The shares were sold at an average price of $65.06, for a total transaction of $1,917,057.96. Following the completion of the sale, the director now owns 45,409 shares of the company's stock, valued at approximately $2,954,309.54. The trade was a 39.35 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 241,360 shares of company stock worth $16,006,428 in the last 90 days. 11.10% of the stock is owned by company insiders.

Ryan Specialty Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Recommended Stories

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads